What is it used for?
KIMMTRAK is indicated for the treatment of HLA-A*02:01-positive adult patients with unresectable or metastatic uveal melanoma.KIMMTRAK is indicated for the treatment of HLA-A*02:01-positive adult patients with unresectable or metastatic uveal melanoma.
Read the primary sourceThis source does not establish current stock, import permission or personal eligibility in China. The treating clinician and provider must confirm these separately.
Product details
- Active ingredient
- tebentafusptebentafusp
- Form and strength
- INJECTION, SOLUTION, CONCENTRATE · 100 ug / 0.5 mLINJECTION, SOLUTION, CONCENTRATE · 100 ug / 0.5 mL
- Manufacturer / applicant
- IMMUNOCORE COMMERCIAL LLCIMMUNOCORE COMMERCIAL LLC
Injection: 100 mcg/0.5 mL clear, colorless to slightly yellowish solution in a single-dose vialInjection: 100 mcg/0.5 mL clear, colorless to slightly yellowish solution in a single-dose vial
Safety and clinical review
Cytokine Release Syndrome (CRS), which may be serious or life-threatening, occurred in patients receiving KIMMTRAK. Monitor for at least 16 hours following first three infusions and then as clinically indicated [(see Dosage and Administration (2.2), see Warnings and Precautions (5.1)].Cytokine Release Syndrome (CRS), which may be serious or life-threatening, occurred in patients receiving KIMMTRAK. Monitor for at least 16 hours following first three infusions and then as clinically indicated [(see Dosage and Administration (2.2), see Warnings and Precautions (5.1)].
- Cytokine Release SyndromeCytokine Release Syndrome
- Skin ReactionsSkin Reactions
- Elevated Liver EnzymesElevated Liver Enzymes
- Embryo-Fetal ToxicityEmbryo-Fetal Toxicity
Ask your clinician to review the complete label, medical history, other medicines, allergies, pregnancy or breastfeeding and any required monitoring. Do not start, stop or change treatment from this page.
Read the primary sourcePrepare your enquiry
Include the brand or generic name, strength, dosage form, requested quantity and country where care is needed. You can attach a prescription when you continue.
Questions patients ask
What is Kimmtrak used for?
KIMMTRAK is indicated for the treatment of HLA-A*02:01-positive adult patients with unresectable or metastatic uveal melanoma.KIMMTRAK is indicated for the treatment of HLA-A*02:01-positive adult patients with unresectable or metastatic uveal melanoma.
This source does not establish current stock, import permission or personal eligibility in China. The treating clinician and provider must confirm these separately.
Which formulation of Kimmtrak should I ask about?
INJECTION, SOLUTION, CONCENTRATE · 100 ug / 0.5 mLINJECTION, SOLUTION, CONCENTRATE · 100 ug / 0.5 mL
Read the primary sourceWhat determines the price of Kimmtrak?
A current quote depends on the exact presentation, quantity, provider and access arrangements. A catalogue entry is not a stock or delivery promise. Medical charges are paid to the provider, separately from coordination fees.
What should I check before using Kimmtrak?
Ask your clinician to review the complete label, medical history, other medicines, allergies, pregnancy or breastfeeding and any required monitoring. Do not start, stop or change treatment from this page.
Sources and review scope
FDA prescribing informationThis source does not establish current stock, import permission or personal eligibility in China. The treating clinician and provider must confirm these separately.